Xeljanz (Tofacitinib) is an expensive drug that works on the immune system. This medicine is used to treat rheumatoid arthritis and psoriatic arthritis. It is also used to treat ulcerative colitis. This drug is more popular than comparable drugs. There are currently no generic alternatives to Xeljanz. While 96% of insurance plans cover the most common version of Xeljanz at a co-pay of $60.00-$83.00, many of them have restrictions. Manufacturer and pharmacy coupons can help offset the cost.

With the Patient Assistance Program from Pfizer, you can receive your medication at no cost.